Highlights
NASDAQ: AGEN       Agenus Inc
Last Price Today's Change   Day's Range   Trading Volume
4.01   -1.12 (21.83%)  3.46 - 4.10  16,052,200

Overview

 
Avg Volume (4 weeks):4,823,700
4 Weeks Range:3.46 - 5.79
4 Weeks Price Volatility (%):
23.61%
52 Weeks Range:2.50 - 6.79
52 Weeks Price Volatility (%):
35.20%
Average Price Target: 11.00
Price Target Upside/Downside: +6.99

Headlines



No recent Headlines for this stock.


Business Background

Agenus Inc is an American biotechnology company. Its main target are immuno-oncology treatments. The company's portfolio consists of therapeutic antibodies and vaccines to treat immuno-oncology illnesses: cancers, shingles, malaria, glioblastoma, and others. Agenus treatments aim, by combining multiple antibody platforms, to stimulate the immune system to recognize and fight cancer cells. The company has been cooperating with companies like Incyte, Merck Sharp & Dohme, and Recepta Biopharma to achieve over a dozen antibody programs.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

4496  5431  869  704 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 PHUN 8.74+7.21 
 MARK 2.17+1.26 
 PROG 2.96+0.46 
 FAMI 0.297-0.023 
 SNAP 55.14-19.97 
 CEI 1.44-0.18 
 CRTD 4.13+1.21 
 PBTS 1.32+0.12 
 DWAC 94.20+48.70 
 INTC 49.46-6.54